Drugs Controller General of India (DCGI)
-
INDIA
DCGI Approves COVID-19 Vaccine Covovax For Kids Aged 7-12
Mumbai: The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute of India’s COVID-19 vaccine Covovax for use…
Read More » -
Top News
Covaxin Gets Approval For Restricted Emergency Use In Children Aged 6-12 Years
Mumbai: Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation to Bharat Biotech’s Covaxin for children between…
Read More » -
Top News
Bharat Biotech’s Intranasal COVID-19 Vaccine Approved For Booster Dose Trials
Mumbai: The Drugs Controller General of India on Friday permitted Bharat Biotech to conduct trials for its intranasal COVID-19 booster…
Read More » -
Top News
DCGI Waiver Likely To Bring Foreign Vaccines Like Pfizer, Moderna A Step Closer
Mumbai: The Drugs Controller General of India (DCGI) has exempted well-established COVID-19 vaccines from clinical trials and testing after approval…
Read More » -
Top News
Covaxin Approved For Phase II-III Trials In 2-18 Years Age Group, Says Niti Aayog Member
Mumbai: NITI Aayog member (health) Dr VK Paul said on Tuesday that Bharat Biotech is set to begin the second…
Read More » -
Top News
Covaxin Phase II/III Clinical Trial For 2-18 Age Group Cleared By DCGI
Mumbai: The Drugs Controller General of India (DCGI) has approved Phase II/III clinical trial of Covaxin in the age group…
Read More » -
Top News
SII Gets DCGI Permission To Manufacture ‘Covishield’
Mumbai: The Drugs Controller General of India (DCGI) has allowed the Pune-based Serum Institute of India (SII) to manufacture its…
Read More »